Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Jackson

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Molecular Cancer Research : MCR|March 7, 2014
Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumorsQin Li, Yun Zhang, Adel K El-Naggar, et al.
Journal of the American Academy of Dermatology|February 5, 2020
Medical students' ability to diagnose common dermatologic conditions in skin of colorAnne Fenton, Erika Elliott, Ashkan Shahbandi, et al.
Cell Death and Differentiation|May 28, 2020
BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancerAshkan Shahbandi, Sonia G Rao, Ashlyn Y Anderson, et al.
Genes & Development|August 27, 2013
The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevityVinod Pant, Shunbin Xiong, James G Jackson, et al.
Molecular and Cellular Biology|March 31, 2005
MRG15 regulates embryonic development and cell proliferationKaoru Tominaga, Bhakti Kirtane, James G Jackson, et al.
Cell Stem Cell|November 3, 2010
Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activityHussein A Abbas, Daniela R Maccio, Suleyman Coskun, et al.
The Journal of Clinical Investigation|February 3, 2011
Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutationYongxing Wang, Young-Ah Suh, Maren Y Fuller, et al.
Cancer Research|October 11, 2011
Multiple stress signals activate mutant p53 in vivoYoung-Ah Suh, Sean M Post, Ana C Elizondo-Fraire, et al.
NAR Cancer|March 7, 2022
Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor developmentVivian S Park, Meijuan J S Sun, Wesley D Frey, et al.
Cancer Cell|September 14, 2010
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor developmentSean M Post, Alfonso Quintás-Cardama, Vinod Pant, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Molecular Cancer Research : MCR|March 7, 2014
Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumorsQin Li, Yun Zhang, Adel K El-Naggar, et al.
Journal of the American Academy of Dermatology|February 5, 2020
Medical students' ability to diagnose common dermatologic conditions in skin of colorAnne Fenton, Erika Elliott, Ashkan Shahbandi, et al.
Cell Death and Differentiation|May 28, 2020
BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancerAshkan Shahbandi, Sonia G Rao, Ashlyn Y Anderson, et al.
Genes & Development|August 27, 2013
The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevityVinod Pant, Shunbin Xiong, James G Jackson, et al.
Molecular and Cellular Biology|March 31, 2005
MRG15 regulates embryonic development and cell proliferationKaoru Tominaga, Bhakti Kirtane, James G Jackson, et al.
Cell Stem Cell|November 3, 2010
Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activityHussein A Abbas, Daniela R Maccio, Suleyman Coskun, et al.
The Journal of Clinical Investigation|February 3, 2011
Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutationYongxing Wang, Young-Ah Suh, Maren Y Fuller, et al.
Cancer Research|October 11, 2011
Multiple stress signals activate mutant p53 in vivoYoung-Ah Suh, Sean M Post, Ana C Elizondo-Fraire, et al.
NAR Cancer|March 7, 2022
Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor developmentVivian S Park, Meijuan J S Sun, Wesley D Frey, et al.
Cancer Cell|September 14, 2010
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor developmentSean M Post, Alfonso Quintás-Cardama, Vinod Pant, et al.
Pageof 4